AR075353A1 - Diseno de electrodos de sacrificio y especies de administracion adecuadas para periodos de aplicacion prolongadas de iontoforesis - Google Patents

Diseno de electrodos de sacrificio y especies de administracion adecuadas para periodos de aplicacion prolongadas de iontoforesis

Info

Publication number
AR075353A1
AR075353A1 ARP090103349A ARP090103349A AR075353A1 AR 075353 A1 AR075353 A1 AR 075353A1 AR P090103349 A ARP090103349 A AR P090103349A AR P090103349 A ARP090103349 A AR P090103349A AR 075353 A1 AR075353 A1 AR 075353A1
Authority
AR
Argentina
Prior art keywords
administration
adequate
extended
design
anode
Prior art date
Application number
ARP090103349A
Other languages
English (en)
Spanish (es)
Original Assignee
Travanti Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Travanti Pharma Inc filed Critical Travanti Pharma Inc
Publication of AR075353A1 publication Critical patent/AR075353A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP090103349A 2008-09-02 2009-09-01 Diseno de electrodos de sacrificio y especies de administracion adecuadas para periodos de aplicacion prolongadas de iontoforesis AR075353A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9346408P 2008-09-02 2008-09-02

Publications (1)

Publication Number Publication Date
AR075353A1 true AR075353A1 (es) 2011-03-30

Family

ID=41797371

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090103349A AR075353A1 (es) 2008-09-02 2009-09-01 Diseno de electrodos de sacrificio y especies de administracion adecuadas para periodos de aplicacion prolongadas de iontoforesis

Country Status (17)

Country Link
US (1) US8295923B2 (https=)
EP (1) EP2331200B1 (https=)
JP (1) JP5255121B2 (https=)
KR (1) KR101267737B1 (https=)
CN (1) CN102186535B (https=)
AR (1) AR075353A1 (https=)
AU (1) AU2009288751B2 (https=)
BR (1) BRPI0918088A2 (https=)
CA (1) CA2735785C (https=)
EA (1) EA021365B1 (https=)
ES (1) ES2481668T3 (https=)
IL (1) IL211504A (https=)
MX (1) MX2011002373A (https=)
NZ (1) NZ591333A (https=)
TW (1) TWI454244B (https=)
WO (1) WO2010027444A1 (https=)
ZA (1) ZA201101328B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8386029B2 (en) 2005-03-31 2013-02-26 Encore Medical Asset Corporation Apparatus for electrotherapy drug delivery with added impurities
US20120259269A1 (en) 2011-04-08 2012-10-11 Tyco Healthcare Group Lp Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
US10675254B2 (en) 2013-10-11 2020-06-09 Teikoku Seiyaku Co., Ltd. Sphingosine-1-phosphate receptor agonist iontophoretic devices and methods of using the same
US20150265825A1 (en) * 2014-03-21 2015-09-24 L'oreal Combined sonic and iontophoretic skin care device
ITUB20156242A1 (it) * 2015-12-04 2017-06-04 Rossi Elisabetta Supporto per applicazione transdermica di sostanza
US10179038B2 (en) * 2015-12-30 2019-01-15 Colgate-Palmolive Company Oral care device with sacrificial electrode
AU2019286260B2 (en) 2018-06-11 2022-05-12 Colgate-Palmolive Company Oral care device
US11019918B2 (en) 2018-06-11 2021-06-01 Colgate-Palmolive Company Oral care device
KR101959524B1 (ko) * 2018-09-19 2019-03-18 주식회사 우신라보타치 리도카인을 포함한 이온토포레시스용 점착성 카타플라스마 시스템
CN112111071B (zh) * 2019-06-21 2021-09-21 清华大学 传感器及其制备方法，以及传感器的使用方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744787A (en) 1984-10-29 1988-05-17 Medtronic, Inc. Iontophoresis apparatus and methods of producing same
US6004309A (en) * 1990-03-30 1999-12-21 Alza Corporation Method and apparatus for controlled environment electrotransport
US5503632A (en) * 1994-04-08 1996-04-02 Alza Corporation Electrotransport device having improved cathodic electrode assembly
US6425892B2 (en) * 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US6858018B1 (en) * 1998-09-28 2005-02-22 Vyteris, Inc. Iontophoretic devices
US6611706B2 (en) * 1998-11-09 2003-08-26 Transpharma Ltd. Monopolar and bipolar current application for transdermal drug delivery and analyte extraction
KR20010110754A (ko) * 1999-04-13 2001-12-13 나까도미 히로다카 이온토포레시스 디바이스
JP2000300682A (ja) * 1999-04-23 2000-10-31 Hisamitsu Pharmaceut Co Inc イオントフォレーシス用デバイス
US6731977B2 (en) 2001-01-22 2004-05-04 Iomed, Inc. Iontophoretic electrode with improved current distribution
DE10141254C1 (de) * 2001-08-23 2003-04-03 Susann Edel Iontophorese-Kaltkontaktelektrodensystem zur gleichzeitigen Anwendung der Kühlung und der Iontophorese
EP1484084A4 (en) * 2002-01-24 2009-12-23 Hisamitsu Pharmaceutical Co ELECTRODE STRUCTURE
US6975902B2 (en) * 2002-06-28 2005-12-13 Alza Corporation Reservoir and a series of related reservoirs for use in an electrotransport drug delivery device and devices comprised thereof
US6745071B1 (en) 2003-02-21 2004-06-01 Birch Point Medical, Inc. Iontophoretic drug delivery system
US7031769B2 (en) * 2003-02-21 2006-04-18 Birch Point Medical, Inc. Dosage control electrode for iontophoresis device
US7031796B2 (en) 2003-09-03 2006-04-18 Kla-Tencor Technologies Corporation Radiation damage reduction
US20050228335A1 (en) * 2004-04-07 2005-10-13 Reddy Vilambi N Physical, structural, mechanical, electrical and electromechanical features for use in association with electrically assisted delivery devices and systems
US20070083186A1 (en) * 2005-09-30 2007-04-12 Darrick Carter Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
US20080009782A1 (en) * 2006-06-28 2008-01-10 Alza Corporation Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
US8214030B2 (en) * 2006-09-06 2012-07-03 Encore Medical Asset Corporation Iontophoresis apparatus and method
US7904146B2 (en) * 2006-11-13 2011-03-08 Travanti Pharma Inc. Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions
US20080154230A1 (en) * 2006-12-20 2008-06-26 Janardhanan Anand Subramony Anode for electrotransport of cationic drug

Also Published As

Publication number Publication date
AU2009288751A1 (en) 2010-03-11
ES2481668T3 (es) 2014-07-31
US8295923B2 (en) 2012-10-23
KR101267737B1 (ko) 2013-05-24
JP2012501213A (ja) 2012-01-19
IL211504A (en) 2014-09-30
CN102186535B (zh) 2015-09-30
JP5255121B2 (ja) 2013-08-07
CN102186535A (zh) 2011-09-14
AU2009288751B2 (en) 2013-02-07
BRPI0918088A2 (pt) 2015-12-08
ZA201101328B (en) 2012-05-30
TW201014564A (en) 2010-04-16
HK1161565A1 (en) 2012-07-27
IL211504A0 (en) 2011-05-31
NZ591333A (en) 2012-09-28
MX2011002373A (es) 2011-06-20
EP2331200B1 (en) 2014-05-21
EA201100429A1 (ru) 2011-10-31
KR20110063509A (ko) 2011-06-10
EA021365B1 (ru) 2015-06-30
CA2735785C (en) 2015-01-27
US20110245755A1 (en) 2011-10-06
EP2331200A1 (en) 2011-06-15
TWI454244B (zh) 2014-10-01
EP2331200A4 (en) 2011-10-12
CA2735785A1 (en) 2010-03-11
WO2010027444A1 (en) 2010-03-11

Similar Documents

Publication Publication Date Title
AR075353A1 (es) Diseno de electrodos de sacrificio y especies de administracion adecuadas para periodos de aplicacion prolongadas de iontoforesis
RU2009118942A (ru) Способ стимуляции регенерации тканей
EA201190300A1 (ru) Микроэлектрод и множественные микроэлектроды, содержащие устройства для высвобождения лекарственных средств в ткани
CL2016000950A1 (es) Composición farmacéutica acuosa que comprende insulina glulisina y metionina; kit farmacéutico; uso en el tratamiento de la diabetes tipo 1 ó 2.
ATE516849T1 (de) Elektrodenanordnung für gleichmässigen neuralen druck mit mehreren befestigungspunkten
CR10347A (es) Anticuerpos contra el peptidob-amiloide
BRMU8901002Y8 (pt) disposição construtiva para uma bandagem portadora de um dispositivo estimulador de nervos transcutâneo elétrico
AR084111A1 (es) Deteccion de entrada tactil y generacion de estimulo tactil perceptible
CL2012002173A1 (es) Combinacion de al menos un estimulador o activador de la sgc con un inhibidor de la pde5; formulacion farmaceutica; y uso para el tratamiento de la fibrosis quistica.
NI201000093A (es) Toalla para llevar puesta
ATE539793T1 (de) Retina-implantat mit einem grundkörper
GT200800250A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
BR112014011067A2 (pt) proteção absorvente descartável
BR112015010504A2 (pt) uso de inibidores de molécula pequena de malt1, método de identificação de um modulador de molécula pequena de malt1, e composição farmacêutica
AR082595A1 (es) Aplicador de dosis unica y metodo
UY30918A1 (es) Moduladores de lta4h y sus usos
EA201100455A1 (ru) Стимулирующее устройство
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
AR077125A1 (es) Combinaciones farmaceuticas utiles para tratar el vhc
PE20081303A1 (es) Composicion farmaceutica que comprende un inhibidor de desacetilasa de histona y un antimetabolito
SV2010003694A (es) Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de leucotrieno a4 hidrolasa
CL2012002560A1 (es) Metodos para el tratamiento de ulceras de pie diabetico que comprende un peptido de al menos 5 aminoacidos contiguos de nle3 a(1-7) efectivo; formulacion farmacéutica que comprende hidroxietil celulosa (hec) y un peptido de al menos 5 aminoacidos contiguos de nle3 a(1-7).
JP2012501213A5 (https=)
AR084772A1 (es) Electrodo para evolucion de oxigeno en procesos electroquimicos industriales
AR074046A1 (es) Envase para la administracion iontoforetica de un farmaco

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee